1
|
Male
|
59
|
Chest pain
|
5
|
Basaloid carcinoma
|
Y
|
Stable
|
2
|
Male
|
51
|
Back pain
|
7.4
|
Squamous-cell carcinoma
|
Y
|
Dead
|
3
|
Female
|
46
|
Back pain
|
5.5
|
Squamous-cell carcinoma
|
Y
|
Stable
|
4
|
Male
|
55
|
Chest pain
|
3.7
|
Atypical carcinoid
|
Y
|
Stable
|
5
|
Male
|
40
|
Asymptomatic
|
7
|
Atypical carcinoid
|
Y
|
Stable
|
6
|
Female
|
47
|
Myasthenia gravis
|
7
|
Squamous-cell carcinoma
|
Y
|
Stable
|
7
|
Male
|
34
|
Chest distress
|
5.5
|
Squamous-cell carcinoma
|
Y
|
Stable
|
8
|
Male
|
43
|
Superior vena cava syndrome
|
5
|
Atypical carcinoid
|
Y
|
Dead
|
9
|
Female
|
52
|
Myasthenia gravis
|
6
|
Squamous-cell carcinoma
|
Y
|
Stable
|
10
|
Male
|
23
|
Superior vena cava syndrome
|
7.2
|
Undifferentiated carcinoma
|
Y
|
Dead
|
11
|
Male
|
26
|
Hypokalemia
|
5
|
Undifferentiated carcinoma
|
Y
|
Dead
|
12
|
Female
|
52
|
Asymptomatic
|
5
|
Squamous-cell carcinoma
|
Y
|
Stable
|
13
|
Male
|
53
|
Chest pain
|
12.7
|
Squamous-cell carcinoma
|
N
|
Dead
|
14
|
Male
|
65
|
Myasthenia gravis
|
5.8
|
Squamous-cell carcinoma
|
N
|
Dead
|
15
|
Male
|
46
|
Asymptomatic
|
4.2
|
Undifferentiated carcinoma
|
N
|
Dead
|
16
|
Male
|
53
|
Shoulder Pain
|
6.9
|
Squamous-cell carcinoma
|
N
|
Dead
|
17
|
Male
|
58
|
Asymptomatic
|
5.8
|
Atypical carcinoid
|
N
|
Dead
|
18
|
Female
|
62
|
Myasthenia gravis
|
6
|
Squamous-cell carcinoma
|
N
|
Stable
|
19
|
Female
|
59
|
Asymptomatic
|
9.2
|
Squamous-cell carcinoma
|
N
|
Dead
|
20
|
Male
|
67
|
Chest pain
|
6
|
Undifferentiated carcinoma
|
N
|
Dead
|
21
|
Male
|
51
|
Chest distress
|
16.2
|
Squamous-cell carcinoma
|
N
|
Stable
|
22
|
Male
|
53
|
Superior vena cava syndrome
|
5
|
Undifferentiated carcinoma
|
N
|
Lung metastasis
|
23
|
Female
|
39
|
Asymptomatic
|
6.6
|
Basaloid carcinoma
|
N
|
Dead
|
24
|
Male
|
53
|
Chest pain
|
8.7
|
Squamous-cell carcinoma
|
N
|
Lung metastasis
|
25
|
Male
|
60
|
Chest pain
|
9.4
|
Squamous-cell carcinoma
|
N
|
Dead
|
26
|
Male
|
20
|
Myasthenia gravis
|
5.5
|
Atypical carcinoid
|
N
|
Stable
|